News Home

Where Does Eyenovia Inc (EYEN) Stock Fall in the Biotechnology Field After It Is Higher By 39.05% This Week?

Friday, March 01, 2024 12:40 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Eyenovia Inc (EYEN) Stock Fall in the Biotechnology Field After It Is Higher By 39.05% This Week?

A rating of 80 puts Eyenovia Inc (EYEN) near the top of the Biotechnology industry according to InvestorsObserver. Eyenovia Inc's score of 80 means it scores higher than 80% of stocks in the industry. Eyenovia Inc also received an overall rating of 68, putting it above 68% of all stocks. Biotechnology is ranked 15 out of the 148 industries.

Overall Score - 68
EYEN has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on EYEN!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Eyenovia Inc Stock Today?

Eyenovia Inc (EYEN) stock is trading at $2.35 as of 12:32 PM on Friday, Mar 1, an increase of $0.18, or 8.54% from the previous closing price of $2.17. The stock has traded between $2.08 and $2.36 so far today. Volume today is above average. So far 1,059,798 shares have traded compared to average volume of 699,240 shares. Click Here to get the full Stock Report for Eyenovia Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App